Anoop Kumar Singh

Array ( [id] => 9183450 [patent_doc_number] => 08623382 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-07 [patent_title] => 'Immunogenic compositions for inducing an immune response to HIV' [patent_app_type] => utility [patent_app_number] => 13/008694 [patent_app_country] => US [patent_app_date] => 2011-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 37767 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 224 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13008694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8431008 [patent_doc_number] => 20120252883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'Method and Composition to Increase Radiation-Induced Tumor Therapeutic Effects' [patent_app_type] => utility [patent_app_number] => 13/513890 [patent_app_country] => US [patent_app_date] => 2010-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 15329 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13513890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8227840 [patent_doc_number] => 20120142049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'Recombinant Gene Expression' [patent_app_type] => utility [patent_app_number] => 12/960541 [patent_app_country] => US [patent_app_date] => 2010-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13651 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12960541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6202336 [patent_doc_number] => 20110065122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'METHOD FOR ACCESSING MICROBIAL DIVERSITY' [patent_app_type] => utility [patent_app_number] => 12/953549 [patent_app_country] => US [patent_app_date] => 2010-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6556 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065122.pdf [firstpage_image] =>[orig_patent_app_number] => 12953549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10167714 [patent_doc_number] => 09198404 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-01 [patent_title] => 'Maternally induced sterility in animals' [patent_app_type] => utility [patent_app_number] => 13/511317 [patent_app_country] => US [patent_app_date] => 2010-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 8 [patent_no_of_words] => 16383 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13511317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8779582 [patent_doc_number] => 20130101557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-25 [patent_title] => 'Recombinant Adenovirus Having Anti-Angiogenesis Activity' [patent_app_type] => utility [patent_app_number] => 13/519934 [patent_app_country] => US [patent_app_date] => 2010-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10868 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13519934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8417721 [patent_doc_number] => 20120245221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'ANTI-APOPTOTIC AGENTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/505316 [patent_app_country] => US [patent_app_date] => 2010-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 21816 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13505316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5944179 [patent_doc_number] => 20110104799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'Multifunctional Alleles' [patent_app_type] => utility [patent_app_number] => 12/915447 [patent_app_country] => US [patent_app_date] => 2010-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 20916 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104799.pdf [firstpage_image] =>[orig_patent_app_number] => 12915447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5944182 [patent_doc_number] => 20110104802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'PROCEDURE FOR THE UNDIFFERENTIATED OR MYELOID LINEAGE BIASED EXPANSION OF HAEMATOPOIETIC STEM CELLS FROM UMBILICAL CORD BLOOD, MOBILIZED PERIPHERAL BLOOD OR BONE MARROW' [patent_app_type] => utility [patent_app_number] => 12/915878 [patent_app_country] => US [patent_app_date] => 2010-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2488 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104802.pdf [firstpage_image] =>[orig_patent_app_number] => 12915878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8171380 [patent_doc_number] => 20120107401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'OSTEOCONDUCTIVE MATRICES COMPRISING STATINS AND METHODS OF USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/913237 [patent_app_country] => US [patent_app_date] => 2010-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14873 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20120107401.pdf [firstpage_image] =>[orig_patent_app_number] => 12913237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5929351 [patent_doc_number] => 20110039310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'NOVEL GENE SMS 37' [patent_app_type] => utility [patent_app_number] => 12/905282 [patent_app_country] => US [patent_app_date] => 2010-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18890 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20110039310.pdf [firstpage_image] =>[orig_patent_app_number] => 12905282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6030831 [patent_doc_number] => 20110081296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'SYSTEMS AND METHODS FOR IDENTIFICATION OF CILIOPATHY THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 12/890596 [patent_app_country] => US [patent_app_date] => 2010-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 29040 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20110081296.pdf [firstpage_image] =>[orig_patent_app_number] => 12890596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6204340 [patent_doc_number] => 20110067126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'GAB1 INVOLVEMENT IN GLUCOSE HOMEOSTASIS REGULATION BY HEPATOCYTES' [patent_app_type] => utility [patent_app_number] => 12/879946 [patent_app_country] => US [patent_app_date] => 2010-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11787 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20110067126.pdf [firstpage_image] =>[orig_patent_app_number] => 12879946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8405441 [patent_doc_number] => 20120237503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'Screening Method and Therapy with Agonists of DDAH I' [patent_app_type] => utility [patent_app_number] => 13/394876 [patent_app_country] => US [patent_app_date] => 2010-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9738 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13394876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5976849 [patent_doc_number] => 20110070641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations' [patent_app_type] => utility [patent_app_number] => 12/807574 [patent_app_country] => US [patent_app_date] => 2010-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12326 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20110070641.pdf [firstpage_image] =>[orig_patent_app_number] => 12807574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6070674 [patent_doc_number] => 20110045524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'TRANSFECTION READY EUKARYOTIC CELLS' [patent_app_type] => utility [patent_app_number] => 12/861112 [patent_app_country] => US [patent_app_date] => 2010-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11153 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20110045524.pdf [firstpage_image] =>[orig_patent_app_number] => 12861112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5957339 [patent_doc_number] => 20110035815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'Mosaic knockout mouse tumor models and methods or use' [patent_app_type] => utility [patent_app_number] => 12/806302 [patent_app_country] => US [patent_app_date] => 2010-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 28984 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20110035815.pdf [firstpage_image] =>[orig_patent_app_number] => 12806302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6164826 [patent_doc_number] => 20110195050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'USE OF A COMBINATION OF MYXOMA VIRUS AND RAPAMYCIN FOR THERAPEUTIC TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/850599 [patent_app_country] => US [patent_app_date] => 2010-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 16187 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195050.pdf [firstpage_image] =>[orig_patent_app_number] => 12850599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6154807 [patent_doc_number] => 20110023146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'GENOMIC EDITING OF GENES INVOLVED IN SECRETASE-ASSOCIATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/842694 [patent_app_country] => US [patent_app_date] => 2010-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15460 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20110023146.pdf [firstpage_image] =>[orig_patent_app_number] => 12842694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5997064 [patent_doc_number] => 20110016543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'GENOMIC EDITING OF GENES INVOLVED IN INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 12/842999 [patent_app_country] => US [patent_app_date] => 2010-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16943 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20110016543.pdf [firstpage_image] =>[orig_patent_app_number] => 12842999 [rel_patent_id] =>[rel_patent_doc_number] =>)